Uses and Limitations of Nuclear Magnetic Resonance (NMR) Spectroscopy in Clinical Pharmacokinetics

This publication has 29 references indexed in Scilit:

• Prediction of 5-fluorouracil cytotoxicity towards the Walker carcinosarcoma using peak integrals of fluoronucleotides measured by MRS in vivo
  British Journal of Cancer, 1989
• In vivo 19F nuclear magnetic resonance spectroscopy: a potential monitor of 5-fluorouracil pharmacokinetics and metabolism
  Investigational New Drugs, 1989
• METABOLITES OF 5-FLUOROURACIL IN PLASMA AND URINE, AS MONITORED BY F-19 NUCLEAR MAGNETIC-RESONANCE SPECTROSCOPY, FOR PATIENTS RECEIVING CHEMOTHERAPY WITH OR WITHOUT METHOTREXATE PRETREATMENT
  1988
• Solid phase extraction chromatography and NMR spectroscopy (SPEC-NMR) for the rapid identification of drug metabolites in urine
  Journal of Pharmaceutical and Biomedical Analysis, 1988
• F-19 NMR SPECTROMETRY EVIDENCE FOR BILE-ACID CONJUGATES OF ALPHA-FLUORO-BETA-ALANINE AS THE MAIN BILIARY METABOLITES OF ANTINEOPLASTIC FLUOROPYRIMIDINES IN HUMANS
  1988
• Application of fluorine-19 nuclear magnetic resonance to the determination of plasma-protein binding of 5′-deoxy-5-fluorouridine, a new antineoplastic fluoropyrimidine
  Journal of Pharmaceutical and Biomedical Analysis, 1988
• DIRECT DETECTION OF NEW FLUCYTOSINE METABOLITES IN HUMAN BIOFLUIDS BY F-19 NUCLEAR-MAGNETIC-RESONANCE
  1987
• High resolution nuclear magnetic resonance spectroscopy of biological samples as an aid to drug development
  Published by Springer Nature ,1987
• A rapid method for the isolation and identification of drug metabolites from human urine using solid phase extraction and proton NMR spectroscopy
  Journal of Pharmaceutical and Biomedical Analysis, 1986
• Release of fluoride ion from 5'-deoxy-5-fluorouridine, an antineoplastic fluoropyrimidine, in humans.
  1985